Publicacións (94) Publicacións de YASMINA JUARRANZ MORATILLA

2022

  1. Human CD4+CD45RA+ T Cells Behavior after In Vitro Activation: Modulatory Role of Vasoactive Intestinal Peptide

    International Journal of Molecular Sciences, Vol. 23, Núm. 4

  2. VIP/VPAC Axis Expression in Immune-Mediated Inflammatory Disorders: Associated miRNA Signatures

    International journal of molecular sciences, Vol. 23, Núm. 15

2021

  1. Enhanced Susceptibility of Galectin-1 Deficient Mice to Experimental Colitis

    Frontiers in Immunology, Vol. 12

  2. Molecular and Cellular Basis of Autoimmune Diseases

    Cells

  3. Proteomic analysis of synovial fibroblasts and articular chondrocytes co-cultures reveals valuable vip-modulated inflammatory and degradative proteins in osteoarthritis

    International Journal of Molecular Sciences, Vol. 22, Núm. 12

  4. The neuropeptide vip limits human osteoclastogenesis: Clinical associations with bone metabolism markers in patients with early arthritis

    Biomedicines, Vol. 9, Núm. 12

2020

  1. A clinical approach for the use of VIP axis in inflammatory and autoimmune diseases

    International Journal of Molecular Sciences, Vol. 21, Núm. 1

  2. Comparative Study of Senescent Th Biomarkers in Healthy Donors and Early Arthritis Patients. Analysis of VPAC Receptors and Their Influence

    Cells, Vol. 9, Núm. 12

  3. Vasoactive intestinal peptide axis is dysfunctional in patients with Graves’ disease

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Activation of Th lymphocytes alters pattern expression and cellular location of VIP receptors in healthy donors and early arthritis patients

    Scientific Reports, Vol. 9, Núm. 1

  2. An Overview of VPAC Receptors in Rheumatoid Arthritis: Biological Role and Clinical Significance

    Frontiers in Endocrinology, Vol. 10

  3. Profile of Matrix-Remodeling Proteinases in Osteoarthritis: Impact of Fibronectin

    Cells, Vol. 9, Núm. 1

  4. The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases

    Frontiers in Endocrinology, Vol. 10

  5. Wnt and RUNX2 mediate cartilage breakdown by osteoarthritis synovial fibroblast-derived ADAMTS-7 and -12

    Journal of Cellular and Molecular Medicine, Vol. 23, Núm. 6, pp. 3974-3983

2018

  1. Inhibitory role of growth hormone in the induction and progression phases of collagen-induced arthritis

    Frontiers in Immunology, Vol. 9, Núm. MAY

  2. The anti-inflammatory mediator, vasoactive intestinal peptide, modulates the differentiation and function of Th subsets in rheumatoid arthritis

    Journal of Immunology Research, Vol. 2018

  3. Vasoactive intestinal peptide gene polymorphisms, associated with its serum levels, predict treatment requirements in early rheumatoid arthritis

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Efecto del condroitín sulfato en la sinovitis de pacientes con artrosis de rodilla

    Medicina Clinica, Vol. 149, Núm. 1, pp. 9-16

2016

  1. Clinical relevance of VPAC1 receptor expression in early arthritis: Association with IL-6 and disease activity

    PLoS ONE, Vol. 11, Núm. 2

  2. Healthy and Osteoarthritic Synovial Fibroblasts Produce a Disintegrin and Metalloproteinase with Thrombospondin Motifs 4, 5, 7, and 12: Induction by IL-1β and Fibronectin and Contribution to Cartilage Damage

    American Journal of Pathology, Vol. 186, Núm. 9, pp. 2449-2461